Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis: A case report

RATIONALE: Thrombocytopenia caused by linezolid (LZD) is common, with a reported prevalence as high as 11.8%. Platelets typically reach normal levels 7 days after LZD withdrawal. However, recurrent profound thrombocytopenia due to LZD usage and a persistent profound drop in platelet count after LZD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ming-Gui, Wang, Dan, He, Jian-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113018/
https://www.ncbi.nlm.nih.gov/pubmed/30142839
http://dx.doi.org/10.1097/MD.0000000000011997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113018/
https://www.ncbi.nlm.nih.gov/pubmed/30142839
http://dx.doi.org/10.1097/MD.0000000000011997

Ejemplares similares